QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 this-vse-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 chardan-capital-initiates-coverage-on-reviva-pharmaceuticals-with-buy-rating-announces-price-target-of-2

Chardan Capital analyst Rudy Li initiates coverage on Reviva Pharmaceuticals (NASDAQ: RVPH) with a Buy rating and announces ...

 d-boral-capital-maintains-buy-on-reviva-pharmaceuticals-lowers-price-target-to-2

D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and lowers the price target...

 benchmark-maintains-speculative-buy-on-reviva-pharmaceuticals-lowers-price-target-to-7

Benchmark analyst Bruce D. Jackson maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Speculative Buy and lowers the pric...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION